Skip to main content
. 2015 May 15;10(5):e0126153. doi: 10.1371/journal.pone.0126153

Fig 3. Distribution of IL-4, MIP-1α, MIP-1β, and TNFα concentrations among female controls (n = 46); female treatment-naïve GD1 patients (GD U; n = 25), and female ERT-treated GD1 patients (GD1ERT; n = 24).

Fig 3

ERT: Imiglucerase, 15–60 U/kg every other week for 3–6 years.